Articles discussing a Cyclogyl shortage and an FDA orphan drug designation for a retinitis pigmentosa treatment lead Healio/OSN coverage so far in August.
Read some of the month’s best-performing items below.
Round table: Board members address Cyclogyl shortage, pediatric myopia
Cyclopentolate is a key ingredient in Cyclogyl, an ophthalmic solution used for cycloplegic refraction during an eye examination. It is also currently in short supply, according to the FDA. Read more.
FDA grants orphan drug designation to ADX-2191 for retinitis pigmentosa
The FDA has granted orphan drug designation